Trek Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Trek Financial's NBIX Position: Q2 2026 in Review
Trek Financial opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 2,300 shares worth $388K. The stake represents 0.02% of the portfolio and ranks #366 among its holdings. This is a return to the name: Trek Financial previously reported a position in NBIX as recently as Q3 2024.
Trek Financial first reported a position in NBIX in Q1 2024 and has held it in 4 quarters since. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.
- Trek Financial held 2,300 shares of Neurocrine Biosciences worth $388K as of Q2 2026.
- Neurocrine Biosciences was a new Trek Financial position in Q2 2026.
- Neurocrine Biosciences made up 0.02% of Trek Financial's portfolio in Q2 2026, its #366 holding.
- Trek Financial first reported a position in Neurocrine Biosciences in Q1 2024 and has held it in 4 quarters since.
- 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.
Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.